LAP(mut) IL-2 T peptide(Stealthyx Therapeutics)

N/A

Report date: 2023/01/09 16:01:38

Base Information

Drug NameLAP(mut) IL-2 T peptide(Stealthyx Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-2 replacements
TargetsInterleukin-2
Therapy Area/IndicationsKidney NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStealthyx Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStealthyx Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsKidney NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A